4 foods to avoid with asthma
The chronic lung disease asthma is known to trigger difficulty in breathing due to the inflammation of air passages. This condition is usually accompanied by the excess production of mucus in the lungs, which makes breathing a lot more difficult. A person suffering from asthma normally experiences shortness of breath. While medications are available to treat asthma, bringing about nutritional changes is equally important. Avoiding these foods may help prevent the frequency of attacks.
Milk
Drinking milk increases mucus production, which can worsen asthma symptoms. Hence, nutritionists and doctors advise against dairy consumption to avoid triggering an asthma attack. Switching to probiotic foods like Greek yogurt is usually recommended.
Eggs
Eggs are rich sources of nutrients, but they can trigger asthma attacks. Asthma patients with egg allergies can suffer from an attack on consumption. Eggs can also cause asthma flare-ups in some people. Hence, asthma patients are advised to to rely on other protein source like soy, pulses, and tofu. Carefully read the labels of packed foods to make sure they do not contain eggs as an ingredient.
Peanuts
Another allergy-based food that asthma patients need to avoid is peanuts as an asthma attack can be triggered. An anaphylatic shock can cause impaired breathing due to swelling in the throat and a sudden drop in blood pressure.
Shellfish
Shellfish have high amounts of sulfites that are one of the most powerful triggers of asthma attacks. These allergens make steering clear from shellfish and other crustaceans like crabs, crayfish, lobsters, and shrimps all the more important. These foods have high amounts of sulfites present in them.
Avoiding the foods mentioned above can reduce the risk experiencing an asthma attack. However, it is important to be aware of asthma treatment options. Certain medications are well known to provide relief from asthma symptoms for patients.
Tezepelumab is one such medication used for treating asthma. It is a human monoclonal antibody that inhibits inflammation in the airway passages, thus providing relief from asthma symptoms. The medicine is administered through subcutaneous injections using vial and syringe. Apart from Tezepelumab, Nucala or Mepolizumab is used for eosinophilic asthma treatment. The medication reduces need for oral steroids and facilitates better breathing. It is administered using an autoinjector or prefilled syringe.
FASENRA® is an add-on treatment for severe eosinophilic asthma. It can be administered to patients aged 12 and above. The medicine targets eosinophils, which are the key cause of eosinophilic asthma. It is administered every eight weeks after the first three doses. FASENRA® not only helps reduce the frequency of asthma attacks but also improves a patient’s lung function to help them breathe easier.